第一医药(600833) - 2014 Q1 - 季度财报

Financial Performance - Net profit attributable to shareholders rose by 5.34% to CNY 10,311,330.23 year-on-year[7] - Operating revenue grew by 2.83% to CNY 390,653,236.72 compared to the same period last year[7] - Total operating revenue for the current period reached ¥390,653,236.72, an increase of 2.1% compared to ¥379,897,042.45 in the previous period[21] - Net profit increased to ¥10,311,330.23, compared to ¥9,788,921.60 in the previous period, marking a growth of 5.3%[21] - Basic and diluted earnings per share improved to ¥0.0462 from ¥0.0439, representing a growth of 5.2%[21] - Comprehensive income totaled ¥9,811,685.61, a significant recovery from a loss of ¥3,384,328.05 in the previous period[21] Cash Flow - Net cash flow from operating activities increased by 55.35% to CNY 31,252,383.15 year-on-year[7] - Cash flow from operating activities generated a net amount of ¥31,252,383.15, compared to ¥20,117,422.84 in the previous period, reflecting a growth of 55.8%[26] - The net cash flow from operating activities increased to ¥22,814,146.92, up from ¥10,532,370.03 in the previous period, representing a growth of 116.5%[28] - Cash received from other operating activities rose significantly to ¥14,156,495.05 from ¥5,763,520.52, an increase of 145.5%[28] - The cash flow from investment activities showed a net outflow of ¥917,859.24, worsening from a net outflow of ¥219,756.81 in the previous period[28] Assets and Liabilities - Total assets increased by 1.63% to CNY 931,130,394.70 compared to the end of the previous year[7] - Current assets totaled RMB 544,400,942.09, an increase from RMB 526,841,106.23, representing a growth of about 3.03%[15] - Total liabilities rose to RMB 385,181,917.12 from RMB 380,025,845.87, indicating an increase of about 1.53%[16] - The company's equity attributable to shareholders increased to RMB 538,941,161.69 from RMB 529,129,476.08, reflecting a growth of approximately 1.53%[16] - The total current liabilities amounted to RMB 325,081,598.64, up from RMB 319,664,221.00, which is an increase of about 1.29%[16] Shareholder Information - The number of shareholders reached 25,677 at the end of the reporting period[9] - The largest shareholder, Shanghai Xinduda Commercial (Group) Co., Ltd., holds 23.39% of the shares[9] Employee Compensation - The company reported a significant increase in employee compensation payable by 155.43% to CNY 6,423,908.53[10] - The company reported a significant increase in employee compensation liabilities, rising to RMB 6,423,908.53 from RMB 2,514,892.69, which is an increase of approximately 155.73%[16] - The cash paid to employees increased to ¥7,703,670.95 from ¥7,413,064.75, which is an increase of 3.9%[28] Inventory and Receivables - Accounts receivable increased to RMB 153,265,073.74 from RMB 127,346,748.30, showing a growth of around 20.36%[15] - The inventory decreased to RMB 193,329,273.90 from RMB 235,335,513.91, representing a decline of approximately 17.88%[15] Operating Costs - Total operating costs amounted to ¥377,444,012.12, up from ¥366,743,406.35, reflecting a rise of 2.0%[21] - Sales expenses rose to ¥26,802,371.24 from ¥24,756,274.02, an increase of 8.2%[21] - Management expenses decreased to ¥15,584,296.51 from ¥18,396,325.09, a reduction of 15.2%[21]